BioHealth News Archive

Montgomery County Executive Marc Elrich joins Rich Bendis on BioTalk

Montgomery County Executive Marc Elrich joins Rich Bendis on BioTalk

Montgomery County Executive Marc Elrich joins BioTalk to discuss his Career Path, the BioHealth Industry and plans to support the Industry in MoCo. Listen…

Read More
Justin Yang, Biomedical Advanced Research and Development Authority (BARDA) Director of the DRIVe Catalyst Office, Joins Rich Bendis on BioTalk

Justin Yang, Biomedical Advanced Research and Development Authority (BARDA) Director of the DRIVe Catalyst Office, Joins Rich Bendis on BioTalk

BARDA Director of the DRIVe Catalyst Office, Justin Yang, Joins BioTalk to share how BARDA collaborates with the BioHealth Industry, partners with Incubators, and…

Read More
How This Med Tech Startup Pivoted to Fight the Pandemic

How This Med Tech Startup Pivoted to Fight the Pandemic

Across the world in 2019, UNICEF reports that over 2.4 million infants died in their first month of life, the vast majority in the…

Read More
Children’s National Hospital earns 2020 CHIME Digital Health Most Wired recognition | Children’s National Hospital

Children’s National Hospital earns 2020 CHIME Digital Health Most Wired recognition | Children’s National Hospital

Children’s National Hospital has received 2020 Digital Health Most Wired recognition by The College of Healthcare Information Management Executives (CHIME) as a certified level…

Read More
FDA Grants GlycoMimetics Rare Pediatric Disease Designation for Rivipansel for Treatment of Sickle Cell Disease – BioHealth Capital Region

FDA Grants GlycoMimetics Rare Pediatric Disease Designation for Rivipansel for Treatment of Sickle Cell Disease – BioHealth Capital Region

ROCKVILLE, Md.–(BUSINESS WIRE)–Oct. 5, 2020– GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that the U.S. Food and Drug Administration (FDA) has granted the Company a Rare Pediatric Disease designation…

Read More
The unsung mapmakers | Hub

The unsung mapmakers | Hub

In the early days of managing the Johns Hopkins COVID-19 dashboard, experts at the university and those at Esri, the company providing the mapping…

Read More
Life Sciences Go Viral in Maryland

Life Sciences Go Viral in Maryland

When Maryland Gov. Larry Hogan visited Novavax recently, President and CEO Stanley C. Erck shared some welcome news for the governor publicly: Novavax had…

Read More
Qiagen to Complement COVID-19 Testing Portfolio with Novel Kit That Simplifies and Accelerates PCR Analysis for Research – COVID-19 – Hospimedica.com

Qiagen to Complement COVID-19 Testing Portfolio with Novel Kit That Simplifies and Accelerates PCR Analysis for Research – COVID-19 – Hospimedica.com

QIAGEN N.V. (Venlo, Netherlands) plans to launch a novel straightforward approach to viral RNA epidemiology that will significantly simplify and accelerate PCR analysis and…

Read More

Baltimore venture capital firm Catalio Capital Management closes $100M fund – Baltimore Business Journal

Catalio's portfolio includes many notable local biotech companies, including Personal Genome Diagnostics Inc. and Thrive Earlier Detection Corp. Image: George Petrocheilos (right) and R.…

Read More
First Patient Dosed in NexImmune Phase 1/2 Clinical Trial of NEXI-002 in Multiple Myeloma

First Patient Dosed in NexImmune Phase 1/2 Clinical Trial of NEXI-002 in Multiple Myeloma

GAITHERSBURG, MD -- October 6, 2020 – NexImmune, a clinical-stage biotechnology company developing a portfolio of unique non-genetically-engineered T cell immunotherapies, announced today that…

Read More
This Maryland program will pair cyber researchers and entrepreneurial grad students to form startups – Technical.ly Baltimore

This Maryland program will pair cyber researchers and entrepreneurial grad students to form startups – Technical.ly Baltimore

Maryland universities are home to lots of cyber researchers and technologists working on new ways to secure our increasingly technology-reliant society. Those higher education…

Read More
Pipeline – Immunomic Therapeutics

Pipeline – Immunomic Therapeutics

Our allergy assets remain an underpinning of Immunomic Therapeutics’ success, and have enabled our pivot to focus on oncology. In addition to our canine atopic dermatitis…

Read More
VIRTUAL INVESTORS’ CONFERENCE ON BIOHEALTH (November 18, 2020)

VIRTUAL INVESTORS’ CONFERENCE ON BIOHEALTH (November 18, 2020)

IMN’s Virtual Investors’ Conference on BioHealth, taking place November 18, will provide a platform to understand the intersection of securitization across the biotech and…

Read More

Covid-19 drives historic demand for life sciences real estate

All the fundamentals are aligning for the life sciences industry, as Covid-19 accelerates already growing demand for real estate in the sector. Rents are…

Read More
Amytrx Enrolling Clinical Trial of AMTX-100 in Patients with Atopic Dermatitis

Amytrx Enrolling Clinical Trial of AMTX-100 in Patients with Atopic Dermatitis

08 October 2020   Germantown, MD, USA (October 08, 2020) – Amarex Clinical Research, LLC, an NSF International company client, Amytrx Therapeutics ("Amytrx"), recently initiated…

Read More